CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidylinositol 3-kinase, and protein kinase C

Journal of Immunology

Volumn 156, Issue 9, 1996, Pages 3222-3232

  Teng, Joyce M C ^a   Liu, Xiao Rong ^a   Mills, Gordon B ^b   Dupont, Bo ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE C;

ARTICLE; CELL MEDIATED CYTOTOXICITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMINO ACID SEQUENCE; ANTIGENS, CD28; CROSS-LINKING REAGENTS; CYTOPLASMIC GRANULES; CYTOTOXICITY, IMMUNOLOGIC; ENZYME ACTIVATION; HUMANS; ISOENZYMES; KILLER CELLS, NATURAL; LEUKEMIA; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTEIN KINASE C; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED;

EID: 0029932857     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (95)

1. Azuma, M., D. Ito, H. Yagita, K. Okumura, J. H. Phillips, L. L. Lanier, and C. Somoza. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76.
2. Freeman, G. J., J. G. Gribben, V. A. Boussiotis, J. W. Ng, J. V. A. Restivo, L. A. Lombard, G. S. Gray, and L. M. Nadler. 1993. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262:909.
3. Linsley, P. S., E. A. Clark, and J. A. Ledbetter. 1990. T cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB1. Proc. Natl. Acad. Sci. USA 87:5031.
4. Linsley, P. S., and J. A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191.
5. Thompson, C. B., T. Lindsten, J. A. Ledbetter, S. L. Kunkel, H. A. Young, S. J. Emerson, J. M. Leiden, and C. H. June. 1989. CD28 activation pathway regulates the production of multiple T-cell derived lymphokines/cytokines. Proc. Natl. Acad. Sci. USA 86:1333.
6. Lindsten, T., C. H. June, J. A. Ledbetter, G. Stella, and C. B. Thompson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244:339.
7. Damle, N. K., K. Klussman, P. S. Linsley, A. Aruffo, and J. A. Ledbetter. 1992. Differential regulatory effects of intercellular adhesion molecule-1 on costimulation by the CD28 counter-receptor B7. J. Immunol. 149:2541.
8. Damle, N. K., K. Klussman, E. G. Leytz, H. D. Ochs, A. Aruffo, P. S. Linsley, and J. A. Ledbetter. 1993. Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7. Cell. Immunol. 148:144.
9. Mobley, J., E. Ennis, and Y. Shimizu. 1994. Differential activation-dependent regulation of integrin function in cultured human T-leukemic cell lines. Blood 83:1039.
10. Azuma, M., A. Cayabyab, D. Buck, J. H. Philips, and L. L. Lanier. 1992. CD28 interaction with B7 costimulates primary allogenic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J. Exp. Med. 175:353.
11. Lanier, L. L., S. O'Fallon, C. Somoza, J. H. Phillips, P. S. Linsley, K. Okumura, D. Ito, and M. Azuma. 1995. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J. Immunol. 154:97.
12. Azuma, M., A. Cayabyab, D. Buck, J. H. Philips, and L. L. Lanier. 1992. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. J. Immunol. 149:1115.
13. Lu, Y., A. Granelli-Piperno, J. M. Bjorndahl, C. A. Phillips, and J. M. Trevillyan. 1992. CD28-induced T cell activation: evidence for a protein-tyrosine kinase signal transduction pathway. J. Immunol. 149:24.
14. Vandenberghe, P., G. J. Freeman, L. M. Nadler, M. C. Fletcher, M. Kamoun, L. A. Turka, J. A. Ledbetter, C. B. Thompson, and C. H. June. 1992. Antibody and B7/BB1-mediated ligation of the CD28 receptor induces tyrosine phosphorylation in human T cells. J. Exp. Med. 175:951.
15. August, A., and B. Dupont. 1994. CD28 of T lymphocytes associates with phosphatidylinositol 3-kinase. Int. Immunol. 6:769.
16. Hutchcroft, J. E., and B. Bierer. 1994. Activation-dependent phosphorylation of the T-lymphocyte surface receptor CD28 and associated proteins. Proc. Natl. Acad. Sci. USA 91:3260.
17. August, A., and B. Dupont. 1994. Activation of Src family kinase lck following CD28 crosslinking in the Jurkat leukemic cell line. Biochem. Biophys. Res. Commun. 199:1446.
18. August, A., S. Gibson, Y. Kawakami, T. Kawakami, G. B. Mills, and B. Dupont. 1994. CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line. Proc. Natl. Acad. Sci. USA 91:9347.
19. Prasad, K. V. S., Y. C. Cai, M. Raab, B. Duckworth, L. Cantley, S. E. Shoelson, and C. E. Rudd. 1994. T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif. Proc. Natl. Acad. Sci. USA 91:2834.
20. Pages, F., M. Ragueneau, R. Rottapel, A. Truneh, J. Nunes, J. Imbert, and D. Olive. 1994. Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signaling. Nature 369:327.
21. Stein, P. H., J. D. Fraser, and A. Weiss. 1994. The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3-kinase. Mol. Cell. Biol. 14:3392.
22. Truitt, K. E., C. M. Hicks, and J. B. Imboden. 1994. Stimulation of CD28 triggers an association between CD28 and phosphatidylinositol 3-kinase in Jurkat T cells. J. Exp. Med. 179:1071.
23. lck. Tissue Antigens 46:155.
24. ras. J. Exp. Med. 180:1067.
25. ras. Eur. J. Immunol. 25:1044.
26. Siegel, J. N., C. H. June, H. Yamade, U. R. Rapp, and L. E. Samelson. 1993. Rapid activation of c-Raf-1 after stimulation of the T-cell receptor or muscarinic receptor type 1 in resting T cells. J. Immunol. 151:4116.
27. Su, B., E. Jacinto, M. Hibi, T. Kallunki, M. Karin, and Y. Ben-Neriah. 1994. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77:727.
28. Bryan, R. G., Y. Li, J.-H. Lai, M. Van, N. R. Rice, R. R. Rich, and T.-H. Tan. 1994. Effect of CD28 signal transduction on c-Rel in human peripheral blood T cells. Mol. Cell. Biol. 14:7933.
29. Chatta, G. S., A. G. Spies, S. Chang, G. J. Mize, P. S. Linsley, J. A. Ledbetter, and D. R. Morris. 1994. Differential regulation of proto-oncogenes c-jun and c-fos in T lymphocytes activated through CD28. J. Immunol. 153:5393.
30. Fraser, J. D., B. A. Irving, G. R. Crabtree, and A. Weiss. 1991. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251:313.
31. Fraser, J. D., and A. Weiss. 1992. Regulation of T-cell lymphokine gene transcription by the accessory molecule CD28. Mol. Cell. Biol. 12:4357.
32. Ghosh, P., T.-H. Tan, N. R. Rice, A. Sica, and H. A. Young. 1993. The interleukin 2 CD28-responsive complex contains at least three members of the NFκB family: c-Rel, p50, and p65. Proc. Natl Acad. Sci. USA 90:1696.
33. Lai, J.-H., and J.-H. Tan. 1994. CD28 signaling causes a sustained down-regulation of IκBα which can be prevented by the immunosuppressant rapamycin. J. Biol. Chem. 269:30077.
34. Geisberg, M., J. A. Trapani, and B. Dupont. 1990. Monoclonal antibodies detecting discrete epitopes of human perform. Tissue Antigens 35:229.
35. Gibson, S., B. Leung, J. A. Squire, M. Hill, N. Arima, P. Goss, D. Hogg, and G. B. Mills. 1993. Identification, cloning, and characterization of a novel human T-cell-specific tyrosine kinase located at the hematopoietic complex on chromosome 5q. Blood 82:1561.
36. Trapani, J. A., K. A. Browne, M. Dawson, and M. J. Smyth. 1993. Immunopurification of functional cytotoxic T-lymphocyte/natural killer cell granzyme B (Asp-ase) activity using a monoclonal antibody. Biochem. Biophys. Res. Commun. 195:910.
37. Vlahos, C., W. F. Matter, K. Y. Hui, and R. F. Brown. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-one-benzopyran-4 - one (LY294002). J. Biol. Chem. 269:5241.
38. + T lymphocytes by staphylococcal enterotoxin B. Int. Immunol. 4:1351.
39. src. Mol. Cell. Biol. 11:1972.
40. Walsh, J. P., K. K. Caldwell, and P. W. Majerus. 1991. Formation of phosphatidylinositol 3-phosphate by isomerization from phosphatidylinositol 4-phosphate. Proc. Natl. Acad. Sci. USA 88:9184.
41. Isaaz, S., K. Baetz, K. Olsen, E. Podack, and G. M. Griffiths. 1995. Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway. Eur. J. Immunol. 25:1071.
42. Serve, H., N. S. Yee, G. Stella, L. Sepp-Lorenzino, J. C. Tan, and P. Besmer. 1995. Differential roles of PI3-kinase and Kit tyrosine 821 in Kit receptor-mediated proliferation, survival and cell adhesion in mast cells. EMBO J. 14:473.
43. Okada, T., L. Sakuma, Y. Fukui, O. Hazeki, and M. Ui. 1994. Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J. Biol. Chem. 269:3563.
44. Okada, T., Y. Kawano, T. Sakakibara, O. Hazeki, and M. Ui. 1994. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipotysis in rat adipocytes. J. Biochem. 269:3568.
45. Truitt, K. E., J. Shi, S. Gibson, L. G. Segal, G. B. Mills, and J. B. Imboden. 1995. CD28 delivers costimulatory signals independently of its association with phosphatidylinositol 3-kinase. J. Immunol. 155:4702.
46. Yano, H., S. Nakanishi, K. Kimura, N. Hanai, Y. Saitoh, Y. Fukui, Y. Nanomura, and Y. Matsuda. 1993. Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J. Biol. Chem. 268:25846.
47. Thelen, M., M. P. Wymann, and H. Langen. 1994. Wortmannin binds specifically to I -phosphatidylinositol 3-kinase while inhibiting guanine nucleotide-binding protein-coupled receptor signaling in neutrophil leukocytes. Proc. Natl. Acad. Sci. USA 91:4960.
48. Cheatham, B., C. J. Vlahos, L. Cheatham, L. Wang, J. Blenis, and C. R. Kahn. 1994. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase. DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 14:4902.
49. Brown, W. J., D. B. DeWald, S. D. Emr, H. Plutner, and W. E. Balch. 1995. Role for phosphatidylinositol 3-kinase in the sorting and transport of newly synthesized lysosomal enzymes in mammalian cells. J. Cell. Biol. 130:781.
50. Vlahos, C. J., W. F. Matter, R. F. Brown, A. E. Traynor-Kaplan, P. G. Heyworth, E. R. Prossnitz, R. D. Ye, P. Marder, J. A. Schelm, and K. J. Rothfuss. 1995. Investigation of neutrophil signal transduction using a specific inhibitor of phosphatidylinositol 3-kinase. J. Immunol. 154:2413.
51. Aruffo, A., and B. Seed. 1987. Molecular cloning of a CD28 cDNA by a high efficiency COS cell expression system. Proc. Natl. Acad. Sci. USA 84:8573.
52. Kanakaraj, P., B. Duckworth, L. Azzoni, M. Kamoun, L. C. Cantley, and B. Perussia. 1994. Phosphatidylinositol-3 kinase activation induced upon FcγRIIIA-ligand interaction. J. Exp. Med. 179:551.
53. 3-OH kinase. Nature 358:157.
54. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
55. Shresta, S., D. M. MacIvor, J. W. Heusel, J. H. Russel, and T. J. Ley. 1995. Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells. Proc. Natl. Acad. Sci. USA 92:5679.
56. Trapani, J. A., M. Symth, V. A. Apostolidis, M. Dawson, and K. A. Browne. 1994. Granule serine proteases are normal nuclear constituents of natural killer cells. J. Biol. Chem. 269:18359.
57. Luton, F., M. Buferne, J. Davoust, A. M. Schmitt-Verhulst, and C. Boyer. 1994. Evidence for protein tyrosine kinase involvement in ligand-induced TCR/CD3 internalization and surface redistribution. J. Immunol. 153:63.
58. June, C. H., J. A. Ledbetter, M. M. Gillespie, T. Lindsten, and C. B. Thompson. 1987. T cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell Biol. 7:4472.
59. Anel, A., M. Buferne, C. Boyer, A. M. Schmitt-Verhulst, and P. Golstein. 1994. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clone is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur. J. Immunol. 24:2469.
60. Stephens, L. R., K. T. Hughes, and R. F. Irvine. 1991. Pathway of phosphatidylinositol(3,4,5)-triphosphate synthesis in activated neutrophils. Nature 351:157.
61. Nakanishi, H., K. A. Brewer, and J. H. Exton. 1993. Activation of the ζ isozyme of protein kinase C by phosphatidylinositol 3,4,5-triphosphate. J. Biol. Chem. 268:13.
62. Naor, Z., H. Dan-cohen, J. Hermon, and R. Limor. 1989. Induction of exocytosis in permeabilized pituitary cells by alpha and beta-type protein kinase C. Proc. Natl. Acad. Sci. USA 86:4501.
63. 2+-independent isozymes of protein kinase C-mediated exocytosis in antigen-stimulated rat basophilic RBL-2H3 cells. J. Biol. Chem. 268:1749.
64. Summers, T. A., and C. E. Creutz. 1985. Phosphorylation of a chromaffin granule-binding protein by protein kinase C. J. Biol. Chem. 260:2437.
65. Johnson, M. S., D. J. MacEwan, J. Simpson, and R. Mitchell. 1993. Characterisation of protein kinase C isoforms and enzymic activity from the αT3-1 gonadotroph-derived cell line. FEBS Lett. 333:67.
66. Budworth, J., and A. Gescher. 1995. Differential inhibition of cytosolic and membrane-derived protein kinase C activity by staurosporine and other kinase inhibitors. FEBS Lett. 362:139.
67. Vente, J. D., S. Kiley, T. Garris, W. Bryant, J. Hooker, K. Posekany, P. Parker, P. Cook, D. Fletcher, and K. Ways. 1995. Phorbol ester treatment of U937 cells with altered protein kinase C content and distribution induces cell death rather than differentiation. Cell Growth Differ. 6:371.
68. Toullec, D., P. Pianetti, H. Coste, P. Bellevergue, T. Grand-Perret, M. Ajakane, V. Baudet, P. Boissin, E. Boursier, F. Loriolle, L. Duhamel, D. Charon, and J. Kirilovsky. 1991. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266:15771.
69. Kishimoto, T. K., K. O'Connor, A. Lee, T. M. Roberts, and T. A. Springer. 1987. Cloning of the β subunit of the leukocyte adhesion proteins: homology to an extracellular matrix receptor defines a novel supergene family. Cell 48:681.
70. Larson, R. S., A. L. Corbi, L. Berman, and T. A. Springer. 1989. Primary structure of the leukocyte function-associated molecule-1 alpha subunit: an integrin with an embedded domain defining a protein superfamily. J. Cell Biol. 108:703.
71. Sugie, K., Y. Minami, T. Kawakami, and A. Uchida. 1995. Stimulation of NK-like YT cells via leukocyte function-associated antigen (LFA)-1: possible involvement of LFA-1-associated tyrosine kinase in signal transduction after recognition of NK target cells. J. Immunol. 154:1691.
72. Gibson, S., A. August, D. Branch, B. Dupont, and G. B. Mills. 1996. Functional lck is required for optimal CD28-mediated activation of the Tec family tyrosine kinase emt/itk. J. Biol. Chem. In press.
73. Alexandropoulos, K., G. Chen, and D. Baltimore. 1995. Proline-rich sequences that bind to SrC homologv 3 domains with individual specificities. Proc. Natl. Acad. Sci. USA 92:3110.
74. Cheng, G., Z. S. Ye, and D. Baltimore. 1994. Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction. Proc. Natl. Acad. Sci. USA 91:8152.
75. fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: implications for T cell costimulation. Proc. Natl. Acad. Sci. USA 92:8891.
76. Yao, L., Y. Kawakami, and T. Kawakami. 1994. The Pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C. Proc. Natl. Acad. Sci. USA 91:9175.
77. Kawakami, Y., L. Yao, M. Tashiro, S. Gibson, G. B. Mills, and T. Kawakami. 1995. Activation and interaction with protein kinase C of a cytoplasmic tyrosine kinase, itk/tsk/emt, upon FcεRI cross-linking on mast cells. J. Immunol. 155: 3556.
78. Bonnema, J. D., L. M. Karnitz, R. A. Schoon, R. T. Abraham, and P. J. Leibson. 1994. Fc receptor stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity. J. Exp. Med. 180:1427.
79. Thompson, P. A., S. J. Gutkind, K. C. Robbins, J. A. Ledbetter, and J. B. Bolen. 1992. Identification of distinct populations of PI-3 kinase activity following T cell activation. Oncogene 7:719.
80. Ding, J., C. J. Vlahos, R. Liu, R. F. Brown, and J. A. Badwey. 1995. Antagonists of phosphatidylinositol 3-kinase block activation of several novel protein kinases in neutrophils. J. Biol. Chem. 270:11684.
81. Hu, P., A. Modino, E. Y. Skolnlk, and J. Schlessinger. 1993. Cloning a novel. ubiquitously expressed human phosphatidylinositol 3-kinase and identification of its binding site on p85. Mol. Cell. Biol. 13:7677.
82. Shibasaki, F., Y. Homma, and T. Takenawa. 1991. Two types of phosphatidylinositol 3-kinase from bovine thymus: monomer and heterodimer form. J. Biol. Chem. 266:8108.
83. Ward, S. G., A. Wilson, L. Turner, J. Westwick, and D. M. Sansom. 1995. Inhibition of CD28-mediated T cell costimulation by the phosphoinositol 3-kinase inhibitor wortmannin. Eur. J. Immunol. 25:526.
84. Keenan, D., D. Kelleher, and A. Long. 1995. Regulation of non-classical protein kinase C isoenzymes in a human T cell line. Eur. J. Immunol. 25:13.
85. Nishizuka, Y. 1992. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607.
86. Newton, A. C. 1993. Interactions of proteins with lipid headgroups: lessons from protein kinase C. Annu. Rev. Biophys. Biomol. Struct. 22:1.
87. Bloemena, E., and R. H. J. Van Oers. 1989. The influence of cyclosporin A on the alternative pathways of human T cell activation in vitro. Eur. J. Immunol. 19:943.
88. Bierer, B. E., S. L. Schreiber, and S. J. Burakoff. 1991. The effect of the immunosuppressant FK-506 on alternative pathways of T cell activation. Eur. J. Immunol. 21:439.
89. Henkart, P. A. 1994. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1:343.
90. Ueta, Y., B. L. Levine, M. L. Huang, G. J. Freeman, L. M. Nadler, C. H. June, and S. G. Ward. 1995. Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion. Int. Immunol. 7:957.
91. Mitra, R. S., T. A. Judge, F. Nestle, L. A. Turka, and B. J. Nickoloff. 1995. Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10: differential modulation of B7-1 (CD80) and B7-2 (CD86) expression. J. Immunol. 154:2668.
92. Prabhu Das, M. R., S. S. Zamvil, F. Borriello, H. L. Weiner, A. H. Sharpe, and V. K. Kuchroo. 1995. Reciprocal expression of costimulatory molecules, B7-I and B7-2, on murine T cells following activation. Eur. J. Immunol. 25:207.
93. + T cells. I. Involvement of the CD80-CD28 adhesion molecules. J. Immunol. 155:118.
94. Nünes, J., S. Klasen, M. Ragueneau, C. Pavon, D. Couez, C. Mawas, M. Bagnasco, and D. Olive. 1993. CD28 mAbs with distinct binding properties differ in their ability to induce T cell activation: analysis of early and late activation events. Int. Immunol. 5:311.
95. Liao, X. C., and D. R. Littman. 1995. Altered T cell receptor signaling and disrupted T cell development in mice lacking itk. Immunity 3:757.